Boston Scientific (BSX) Covered By Piper Jaffray with $31.0 Target; SILVERCREST METALS ORDINARY SHARES (SVCMF) SI Decreased By 0.06%

February 24, 2018 - By Marguerite Chambers

Among 30 analysts covering Boston Scientific Corporation (NYSE:BSX), 24 have Buy rating, 0 Sell and 6 Hold. Therefore 80% are positive. Boston Scientific Corporation has $36 highest and $19 lowest target. $28.93’s average target is 6.36% above currents $27.2 stock price. Boston Scientific Corporation had 90 analyst reports since July 27, 2015 according to SRatingsIntel. Needham upgraded the stock to “Buy” rating in Monday, September 28 report. The firm earned “Buy” rating on Monday, September 25 by Stifel Nicolaus. BMO Capital Markets maintained the stock with “Buy” rating in Thursday, August 31 report. The stock of Boston Scientific Corporation (NYSE:BSX) earned “Hold” rating by Jefferies on Wednesday, November 29. SunTrust maintained the shares of BSX in report on Friday, December 1 with “Buy” rating. BTIG Research maintained the stock with “Hold” rating in Monday, June 26 report. The rating was maintained by Needham with “Buy” on Thursday, August 31. The rating was downgraded by TheStreet on Thursday, August 13 to “Hold”. BMO Capital Markets maintained Boston Scientific Corporation (NYSE:BSX) rating on Friday, October 27. BMO Capital Markets has “Outperform” rating and $32 target. The stock has “Buy” rating by UBS on Tuesday, September 22.

SILVERCREST METALS INC ORDINARY SHARES (OTCMKTS:SVCMF) had a decrease of 0.06% in short interest. SVCMF’s SI was 178,600 shares in February as released by FINRA. Its down 0.06% from 178,700 shares previously. With 110,600 avg volume, 2 days are for SILVERCREST METALS INC ORDINARY SHARES (OTCMKTS:SVCMF)’s short sellers to cover SVCMF’s short positions. The SI to SILVERCREST METALS INC ORDINARY SHARES’s float is 0.4%. The stock increased 4.45% or $0.0802 during the last trading session, reaching $1.8812. About 65,884 shares traded or 32.47% up from the average. SilverCrest Metals Inc. (OTCMKTS:SVCMF) has 0.00% since February 24, 2017 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment increased to 1.04 in Q3 2017. Its up 0.01, from 1.03 in 2017Q2. It improved, as 33 investors sold Boston Scientific Corporation shares while 166 reduced holdings. 43 funds opened positions while 164 raised stakes. 1.21 billion shares or 1.08% less from 1.22 billion shares in 2017Q2 were reported. Contravisory Investment Mgmt reported 22 shares. Caisse De Depot Et Placement Du Quebec invested 0% in Boston Scientific Corporation (NYSE:BSX). Fred Alger Mngmt holds 0.65% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 4.74 million shares. Kistler invested 0% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Robeco Institutional Asset Mngmt Bv has 0.02% invested in Boston Scientific Corporation (NYSE:BSX) for 111,977 shares. Thompson Davis & Company stated it has 0.53% in Boston Scientific Corporation (NYSE:BSX). Connor Clark And Lunn Investment Mngmt Limited reported 0.08% stake. Fifth Third National Bank owns 8,413 shares or 0% of their US portfolio. Nuveen Asset Mgmt Llc stated it has 0.05% of its portfolio in Boston Scientific Corporation (NYSE:BSX). Gateway Inv Advisers Limited Company reported 1.17 million shares. Reilly Fincl Advsr Ltd Limited Liability Company has 0% invested in Boston Scientific Corporation (NYSE:BSX) for 411 shares. Diligent Invsts Limited owns 0.22% invested in Boston Scientific Corporation (NYSE:BSX) for 10,164 shares. Mutual Of America Mngmt Ltd Liability Corporation has 239,966 shares for 0.11% of their portfolio. State Of Alaska Department Of Revenue invested in 0.06% or 39,410 shares. Employees Retirement Association Of Colorado holds 0.05% in Boston Scientific Corporation (NYSE:BSX) or 251,355 shares.

Since August 29, 2017, it had 0 insider purchases, and 12 insider sales for $16.75 million activity. Nanavaty Maulik sold 57,031 shares worth $1.56 million. Another trade for 15,500 shares valued at $440,547 was made by Phalen Michael P. on Monday, October 30. On Tuesday, January 9 the insider Pierce David A sold $139,104. The insider Pratt Timothy A. sold 10,104 shares worth $277,475. $2.26M worth of Boston Scientific Corporation (NYSE:BSX) was sold by Fitzgerald Joseph Michael. 347,137 shares were sold by Bose Supratim, worth $10.11M on Tuesday, October 3.

The stock increased 2.72% or $0.72 during the last trading session, reaching $27.2. About 5.75 million shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 19.12% since February 24, 2017 and is uptrending. It has outperformed by 2.42% the S&P500.

Boston Scientific Corporation develops, makes, and markets medical devices for use in various interventional medical specialties worldwide. The company has market cap of $37.35 billion. It operates through three divisions: Cardiovascular, Rhythm Management, and MedSurg. It has a 357.89 P/E ratio. The firm offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems.

Analysts await Boston Scientific Corporation (NYSE:BSX) to report earnings on April, 26. They expect $0.31 earnings per share, up 6.90% or $0.02 from last year’s $0.29 per share. BSX’s profit will be $425.69 million for 21.94 P/E if the $0.31 EPS becomes a reality. After $0.34 actual earnings per share reported by Boston Scientific Corporation for the previous quarter, Wall Street now forecasts -8.82% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>